Germany's CureVac jumps on the COVID-19 bandwagon
The industry implications of CureVac's intent to raise over $200 million.
Featuring:
Video conversations with senior management of medical, pharma, biopharma, healthcare, telemedicine, health, wellness, and medical device companies
Recent industry news
Friedland's Corner videos